Female hypoactive sexual desire disorder: Epidemiology, diagnosis and treatment

CNS Drugs

Volumn 16, Issue 11, 2002, Pages 745-753

  Warnock, Julia K ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ESTRATEST; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SILDENAFIL;

CLIMACTERIUM; DISTRESS SYNDROME; EMOTION; FEMALE; FEMALE SEXUAL DYSFUNCTION; HAPPINESS; HORMONAL CONTRACEPTION; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; LACTATION; LIFESTYLE; MARITAL THERAPY; MENSTRUAL CYCLE; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; PUERPERIUM; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR;

EID: 0036032466     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200216110-00003     Document Type: Review

References (36)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington, DC: American Psychiatric Association, 1994
2. Goldstein I. Female sexual arousal disorder: new insights. Int J Impot Res 2000; 12 Suppl. 4: 152S-7S
3. Graziottin A. The biological basis of female sexuality. Int Clin Psychopharmacol 1998 Jul 13; 13 Suppl. 6: 1S5-22S
4. Redmond GP. Hormones and sexual function. Int J Fertil Womens Med 1999 Jun-Aug; 44 (4): 193-7
5. Sarrel PM, Whitehead MI. Sex and menopause: Defining the issues. Maturitas 1985 Sep; 7 (3): 217-24
6. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990 Apr; 75 Suppl. 4: 26S-30S
7. Stahl SM. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 2nd Ed. Cambridge: Cambridge University Press, 2000
8. Crenshaw TL, Goldberg JP. Sexual Pharmacology: Drugs that Affect Sexual Function. New York: W.W. Norton and Company, 1996
9. Canale D, Pistoia S. Libido and hormones. CNS Spectrums 2000 Aug; 5 (8): 21-3
10. Waxenberg SE, Finkbiner JA, Drellick ND, et al. The role of hormones in human behavior, 2: Changes in sexual behavior in relation to vaginal smears of breast cancer patients after oophorectomy and adrenalectomy. Psychosom Med 1960; 22: 435-9
11. Rako, S. The hormone of desire: The Truth About Sexuality, Menopause and Testosterone. New York: Harmony Books, 1996
12. Basson R. The female sexual response: A different model. J Sex Marital Ther 2000 Jan-Mar; 26 (1): 51-65
13. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999; 281: 537-44
14. DeCherney AH. Hormone receptors and sexuality in the human female. J Womens Health Gend Based Med 2000; 9 (1): S9-13
15. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985 Jul-Aug; 47 (4): 339-51
16. Sherwin BB. Changes in sexual behavior as a function of plasma sex steroid levels in post-menopausal women. Maturitas 1985 Sep; 7 (3): 225-33
17. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000 Sep 7; 343 (10): 682-8
18. Clayton AH, Clavet GJ, McGarvey EL, et al. Assessment of sexual functioning during the menstrual cycle. J Sex Marital Ther 1999 Oct-Dec; 25 (4): 281-91
19. Gitlin MJ. Effects of depression and antidepressants on sexual functioning. Bull Menninger Clin 1995 Spring; 59 (2): 232-48
20. Warnock JK, Blake CF. Psychiatric aspects of hormonal contraception. In: Clayton AH, Kornstein SG, editors. Women's Textbook of Mental Health. New York: Guilford Press, 2002: 114-31
21. Graham CA, Sherwin BB. The relationship between mood and sexuality in women using oral contraceptive as a treatment for premenstrual symptoms. Psychoneuroendocrinology 1993; 18 (4): 273-81
22. Graham CA, Ramos R, Bancroft J, et al. The effects of steroidal contraceptives on the well-being and sexuality of women: A double-blind, placebo-controlled, two-centre study of combined and progestogen-only methods. Contraception 1995 Dec; 52 (6): 363-9
23. Slap GB. Oral contraceptives and depression: impact, prevalence and cause. J Adolesc Health Care 1981 Sep; 2 (1): 53-64
24. Bancroft J, Sherwin BB, Alexander GM, et al. Oral contraceptives, androgens, and the sexuality of young women. II: The role of androgens. Arch Sex Behav 1991 Apr; 20 (2): 121-35
25. Coenen CM, Thomas CM, Borm GF, et al. Changes in androgens during treatment with four low-dose contraceptives. Contraception 1996 Mar; 53 (3): 171-6
26. Hendrick V, Altshuler LL, Suri R. Hormonal changes in the postpartum and implications for postpartum depression. Psychosomatics 1998 Mar-Apr; 39 (2): 93-101
27. Pfaus JG, Everitt BJ. The psychopharmacology of sexual behaviour. In: Bloom FE, Kupfer D, editors. Psychopharmacology. New York: Raven Press, 1995: 743-58
28. American College of Obstetricians and Gynecologists. Issues in Women's Health. Washington, DC: Office of Public Information, 1992
29. Heiman JR, Meston CM. Evaluating sexual dysfunction in women. Clin Obstet Gynaecol 1997 Sep; 40 (3): 616-29
30. Warnock JK. Hormonal aspects of sexual function in women: Treatment advantages with hormone replacement therapy. Primary Psychiatry 2001; 8 (4): 60-4
31. Davis SR. Androgen treatment in women. Med J Aust 1999; 170 (11): 545-9
32. Fava M, Rankin MA, Alpert JE, et al. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom 1998; 67 (6): 328-31
33. Nurnberg HG, Lauriello J, Hensley PL, et al. Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients. J Clin Psychiatry 1999 Jan; 60 (1): 33-5
34. Salerian AJ, Deibler WE, Vittone BJ, et al. Sildenafil for psychotropic-induced sexual dysfunction in 31 women and 61 men. J Sex Marital Ther 2000 Apr-Jun; 26 (2): 133-40
35. Segraves RT, Croft H, Kavoussi R, et al. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women. J Sex Marital Ther 2001; 27 (3): 303-16
36. Clayton AH, McGarvey EL, Warnock JK, et al. Bupropion as a treatment for SSRI-induced sexual dysfunction. Female Sexual Functioning Forum; 2000 Oct 26-29; Boston (MA)